News on Medial

Related News

Exclusive: Gauri Khan Family Trust to back Pandorum in ongoing Series B

EntrackrEntrackr · 9d ago
Exclusive: Gauri Khan Family Trust to back Pandorum in ongoing Series B
Medial

Exclusive: Gauri Khan Family Trust to back Pandorum in ongoing Series B Pandorum Technologies, a Bengaluru-based biotechnology startup, is raising an additional Rs 71.5 crore ($8 million) in its ongoing Series B round, led by Trufort Fund Limited, with participation from Gauri Khan Family Trust and others. Pandorum Technologies is raising additional funds in its Series B round, led by Trufort Fund Limited, and including contributions from Gauri Khan Family Trust and existing investors like Protons Corporate and Noblevast Advisory. Previously, they raised a $10 million tranche led by Protons Corporate. The board has issued 29,893 Series B cumulative compulsory convertible preference shares at Rs 23,920 each, according to the Registrar of Companies (RoC). Trufort Fund Ltd will invest Rs 20 crore, Protons Corporate and Saumik Doshi Rs 10 crore each, Noblevast Advisory Rs 9.5 crore, and Gauri Khan Family Trust Rs 5 crore. Avinya Ventures and others will cover the remaining Rs 27 crore. The fresh capital will support operational needs, expansion initiatives, and subsidiaries. The company’s valuation is expected to be around Rs 822 crore ($91 million) post-money. Founded in 2011 by Arun Chandru and Tuhin Bhowmick, Pandorum Technologies develops lab-grown human tissues for drug discovery and regenerative medicine, offering engineered liver and corneal models for pharmaceutical testing. To date, the company has raised around $43 million, including $11 million as an extension of its Series A. Pandorum is yet to file FY25 numbers. In FY24, the company remained pre-revenue with losses of Rs 28.2 crore.

Download the medial app to read full posts, comements and news.